BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25178878)

  • 1. Diagnosis and management of solid benign liver lesions.
    Belghiti J; Cauchy F; Paradis V; Vilgrain V
    Nat Rev Gastroenterol Hepatol; 2014 Dec; 11(12):737-49. PubMed ID: 25178878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic adenoma: evolution of a more individualized treatment approach.
    Aziz H; Underwood PW; Gosse MD; Afyouni S; Kamel I; Pawlik TM
    J Gastrointest Surg; 2024 Mar; ():. PubMed ID: 38521190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of hepatocyte phase imaging from infancy to young adulthood in patients with a known or suspected liver lesion.
    Kolbe AB; Podberesky DJ; Zhang B; Towbin AJ
    Pediatr Radiol; 2015 Mar; 45(3):354-65. PubMed ID: 25246096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of fortuitously discovered focal liver lesions: additional information provided by shearwave elastography.
    Ronot M; Di Renzo S; Gregoli B; Duran R; Castera L; Van Beers BE; Vilgrain V
    Eur Radiol; 2015 Feb; 25(2):346-58. PubMed ID: 25231131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of hypervascular liver lesions based on hepatic artery and portal vein blood supply coefficients calculated from triphasic CT scans.
    Boas FE; Kamaya A; Do B; Desser TS; Beaulieu CF; Vasanawala SS; Hwang GL; Sze DY
    J Digit Imaging; 2015 Apr; 28(2):213-23. PubMed ID: 25183580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular classification of hepatocellular adenoma in clinical practice.
    Nault JC; Paradis V; Cherqui D; Vilgrain V; Zucman-Rossi J
    J Hepatol; 2017 Nov; 67(5):1074-1083. PubMed ID: 28733222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic hemangiomas: the various imaging avatars and its mimickers.
    Mathew RP; Sam M; Raubenheimer M; Patel V; Low G
    Radiol Med; 2020 Sep; 125(9):801-815. PubMed ID: 32249391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary benign liver lesions.
    Grazioli L; Ambrosini R; Frittoli B; Grazioli M; Morone M
    Eur J Radiol; 2017 Oct; 95():378-398. PubMed ID: 28987695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights in the management of Hepatocellular Adenoma.
    Klompenhouwer AJ; de Man RA; Dioguardi Burgio M; Vilgrain V; Zucman-Rossi J; Ijzermans JNM
    Liver Int; 2020 Jul; 40(7):1529-1537. PubMed ID: 32464711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular adenoma: An unsolved diagnostic enigma.
    Renzulli M; Clemente A; Tovoli F; Cappabianca S; Bolondi L; Golfieri R
    World J Gastroenterol; 2019 May; 25(20):2442-2449. PubMed ID: 31171888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular adenoma: Classification, variants and clinical relevance.
    Bioulac-Sage P; Sempoux C; Balabaud C
    Semin Diagn Pathol; 2017 Mar; 34(2):112-125. PubMed ID: 28131467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EASL Clinical Practice Guidelines on the management of benign liver tumours.
    European Association for the Study of the Liver (EASL)
    J Hepatol; 2016 Aug; 65(2):386-98. PubMed ID: 27085809
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis and treatment of benign liver nodules: Brazilian Society of Hepatology (SBH) recommendations.
    Strauss E; Ferreira Ade S; França AV; Lyra AC; Barros FM; Silva I; Garcia JH; Parise ER
    Arq Gastroenterol; 2015 Dec; 52 Suppl 1():47-54. PubMed ID: 26959805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal Nodular Hyperplasia and Hepatic Adenoma: Evaluation and Management.
    Myers L; Ahn J
    Clin Liver Dis; 2020 Aug; 24(3):389-403. PubMed ID: 32620279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma.
    Roncalli M; Sciarra A; Tommaso LD
    Clin Mol Hepatol; 2016 Jun; 22(2):199-211. PubMed ID: 27189732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign Liver Tumors.
    Oldhafer KJ; Habbel V; Horling K; Makridis G; Wagner KC
    Visc Med; 2020 Aug; 36(4):292-303. PubMed ID: 33005655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Hemangioma: Review of Imaging and Therapeutic Strategies.
    Kacała A; Dorochowicz M; Matus I; Puła M; Korbecki A; Sobański M; Jacków-Nowicka J; Patrzałek D; Janczak D; Guziński M
    Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of magnetic resonance imaging in liver metastases.
    Huang XL; Wang XD; Gong ZM; Zheng YF; Mao JX
    World J Gastroenterol; 2024 Jan; 30(1):112-114. PubMed ID: 38293328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular Carcinoma Arising from Hepatocellular Adenoma in an Elderly Male Patient.
    Lim M; Kim JM; Kwon JE; Jeong ES; Yang J; Lee O; Kim KD; Kim SJ; Rhu J; Choi GS; Joh JW
    J Liver Cancer; 2021 Mar; 21(1):87-91. PubMed ID: 37384277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of progestin-only hormonal use on hepatocellular adenomas: A retrospective cohort study.
    Qureshy Z; Lokken RP; Kakar S; Grab J; Mehta N; Sarkar M
    Contraception; 2023 Mar; 119():109915. PubMed ID: 36476331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.